Pralsetinib is a selective and next-generation RET inhibitor (IC50: 0.3-0.4 nM for WT RET, RET mutants V804L, V804M, M918T, and CCDC6-RET fusion). BLU-667 is an effective and selective inhibitor of RET mutations, fusions, and predicted resistant mutants.
Molecular Weight:
570.07
Formula:
C27H33ClFN9O2
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
